Valuation: Elekta AB (publ)

Market Cap 1.85TCr 193.81Cr 168.48Cr 156.82Cr 143.98Cr 271.9Cr 19TCr 276.11Cr 725.49Cr 9.21TCr 727.89Cr 711.9Cr 31TCr P/E 2027 *
12.9x
P/E 2028 * 11.5x
Enterprise Value 2.2TCr 230.18Cr 200.1Cr 186.25Cr 171Cr 322.92Cr 22TCr 327.92Cr 861.62Cr 11TCr 864.47Cr 845.48Cr 37TCr EV / Sales 2027 *
1.27x
EV / Sales 2028 * 1.19x
Free-Float
94.03%
Yield 2027 *
5.18%
Yield 2028 * 5.71%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 01/09/2025
Director of Finance/CFO - 01/03/2026
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 69 30/06/2010
Director/Board Member 70 15/09/2011
Chairman 74 03/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 193.81Cr
-0.43%+1.06%+22.80%+4.67% 21TCr
-0.61%+1.82%-1.11%-23.56% 14TCr
+0.10%+4.69%-26.56%+8.92% 12TCr
+1.59%+5.60%-55.46%-9.87% 6.95TCr
-0.98%+4.16%+8.52%+4.87% 4.96TCr
-0.91%+5.13%-22.07%-30.22% 4.72TCr
-0.25%-0.14%+20.52%+13.63% 3.91TCr
-0.79%+0.70%+30.67%+36.60% 3.7TCr
-2.75%+12.28%-4.63%-12.79% 3.07TCr
Average -0.39%+3.87%-3.03%-0.86% 8.32TCr
Weighted average by Cap. -0.35%+3.04%-1.71%-1.99%

Financials

2027 *2028 *
Net sales 1.73TCr 181.52Cr 157.79Cr 146.87Cr 134.85Cr 254.65Cr 17TCr 258.59Cr 679.46Cr 8.63TCr 681.71Cr 666.73Cr 29TCr 1.81TCr 189.33Cr 164.58Cr 153.19Cr 140.65Cr 265.6Cr 18TCr 269.72Cr 708.69Cr 9TCr 711.04Cr 695.42Cr 30TCr
Net income 142.96Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 56Cr 712.33Cr 56Cr 55Cr 2.39TCr 160.67Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.61TCr 24Cr 63Cr 800.61Cr 63Cr 62Cr 2.68TCr
Net Debt 346.86Cr 36Cr 32Cr 29Cr 27Cr 51Cr 3.47TCr 52Cr 136.13Cr 1.73TCr 136.58Cr 133.58Cr 5.8TCr 300.18Cr 31Cr 27Cr 25Cr 23Cr 44Cr 3TCr 45Cr 117.81Cr 1.5TCr 118.2Cr 115.61Cr 5.02TCr
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-